nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Tolcapone—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Tolcapone—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Tolcapone—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Tolcapone—Anaemia—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Tolcapone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Tolcapone—Asthenia—Teniposide—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Tolcapone—Malaise—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Tolcapone—Pruritus—Teniposide—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Tolcapone—Arrhythmia—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Tolcapone—Alopecia—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Tolcapone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Tolcapone—Mental disorder—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Tolcapone—Vaginal infection—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Tolcapone—Cough—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Tolcapone—Angiopathy—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Tolcapone—Diarrhoea—Teniposide—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Tolcapone—Mediastinal disorder—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Tolcapone—Myalgia—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Tolcapone—Chest pain—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Tolcapone—Alopecia—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Tolcapone—Discomfort—Bleomycin—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Tolcapone—Mental disorder—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Tolcapone—Chills—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Tolcapone—Urine output increased—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Tolcapone—Neoplasm—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Tolcapone—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Tolcapone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Tolcapone—Alopecia—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Tolcapone—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Tolcapone—Confusional state—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Tolcapone—Vision blurred—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Tolcapone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Tolcapone—Tremor—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Tolcapone—Oedema—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Tolcapone—Infection—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Tolcapone—Anaemia—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Tolcapone—Vomiting—Teniposide—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Tolcapone—Agitation—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Tolcapone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Tolcapone—Asthenia—Fludarabine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Tolcapone—Rash—Teniposide—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Tolcapone—Dermatitis—Teniposide—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Tolcapone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Tolcapone—Headache—Teniposide—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Tolcapone—Pruritus—Fludarabine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Tolcapone—Anorexia—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Tolcapone—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Tolcapone—Anaemia—Vincristine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Tolcapone—Agitation—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Tolcapone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Tolcapone—Polyuria—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Tolcapone—Hypotension—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Tolcapone—Diarrhoea—Fludarabine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Tolcapone—Hypertension—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Tolcapone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Tolcapone—Nausea—Teniposide—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Tolcapone—Anaemia—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Tolcapone—Vertigo—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Tolcapone—Myalgia—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Tolcapone—Chest pain—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Tolcapone—Anxiety—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Tolcapone—Paraesthesia—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Tolcapone—Malaise—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Tolcapone—Dyspnoea—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Tolcapone—Hypertension—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Tolcapone—Confusional state—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Tolcapone—Oedema—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Tolcapone—Decreased appetite—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Tolcapone—Myalgia—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Tolcapone—Cough—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Tolcapone—Infection—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Tolcapone—Vomiting—Fludarabine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Tolcapone—Rash—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Tolcapone—Dermatitis—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Tolcapone—Hypertension—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Tolcapone—Pain—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Tolcapone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Tolcapone—Headache—Fludarabine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Tolcapone—Tachycardia—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Tolcapone—Myalgia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Tolcapone—Chest pain—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Tolcapone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Tolcapone—Anxiety—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Tolcapone—Lethargy—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Tolcapone—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Tolcapone—Discomfort—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Tolcapone—Oedema—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Tolcapone—Anorexia—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Tolcapone—Infection—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Tolcapone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Tolcapone—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Tolcapone—Confusional state—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Tolcapone—Nervous system disorder—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Tolcapone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Tolcapone—Hypotension—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Tolcapone—Oedema—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Tolcapone—Nausea—Fludarabine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Tolcapone—Infection—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Tolcapone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Tolcapone—Shock—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Urticaria—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Anorexia—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Tolcapone—Body temperature increased—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Tolcapone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Tolcapone—Irritability—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Tolcapone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Tolcapone—Paraesthesia—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Tolcapone—Mood swings—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Tolcapone—Hypotension—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Tolcapone—Dyspnoea—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Tolcapone—Somnolence—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Tolcapone—Anorexia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Tolcapone—Decreased appetite—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Tolcapone—Hypotension—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Tolcapone—Paraesthesia—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Tolcapone—Pain—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Tolcapone—Constipation—Carmustine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Tolcapone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Tolcapone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Tolcapone—Decreased appetite—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Tolcapone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Tolcapone—Somnolence—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Feeling abnormal—Carmustine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Fatigue—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Asthenia—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Tolcapone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Tolcapone—Constipation—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Tolcapone—Pain—Vincristine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Tolcapone—Asthma—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Tolcapone—Pruritus—Bleomycin—lymphatic system cancer	0.001	0.001	CcSEcCtD
Tolcapone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Tolcapone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000992	0.000992	CcSEcCtD
Tolcapone—Constipation—Mitoxantrone—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Tolcapone—Pain—Mitoxantrone—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Tolcapone—Abdominal pain—Carmustine—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Tolcapone—Body temperature increased—Carmustine—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Tolcapone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000967	0.000967	CcSEcCtD
Tolcapone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000949	0.000949	CcSEcCtD
Tolcapone—Dysuria—Methotrexate—lymphatic system cancer	0.000943	0.000943	CcSEcCtD
Tolcapone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000941	0.000941	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000937	0.000937	CcSEcCtD
Tolcapone—Abdominal pain—Vincristine—lymphatic system cancer	0.000934	0.000934	CcSEcCtD
Tolcapone—Body temperature increased—Vincristine—lymphatic system cancer	0.000934	0.000934	CcSEcCtD
Tolcapone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Tolcapone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Tolcapone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Tolcapone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Tolcapone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Tolcapone—Pneumonia—Methotrexate—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Tolcapone—Vomiting—Bleomycin—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Tolcapone—Infestation NOS—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Tolcapone—Infestation—Methotrexate—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Tolcapone—Rash—Bleomycin—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Tolcapone—Dermatitis—Bleomycin—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Tolcapone—Asthenia—Carmustine—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Tolcapone—Stomatitis—Methotrexate—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Tolcapone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000871	0.000871	CcSEcCtD
Tolcapone—Sweating—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Tolcapone—Haematuria—Methotrexate—lymphatic system cancer	0.000857	0.000857	CcSEcCtD
Tolcapone—Epistaxis—Methotrexate—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Tolcapone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Tolcapone—Asthenia—Vincristine—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Tolcapone—Diarrhoea—Carmustine—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Tolcapone—Nausea—Bleomycin—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Tolcapone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000826	0.000826	CcSEcCtD
Tolcapone—Dizziness—Carmustine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Tolcapone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Tolcapone—Diarrhoea—Vincristine—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Tolcapone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Tolcapone—Pharyngitis—Methotrexate—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Tolcapone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000788	0.000788	CcSEcCtD
Tolcapone—Vomiting—Carmustine—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Tolcapone—Dizziness—Vincristine—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Tolcapone—Rash—Carmustine—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Tolcapone—Dermatitis—Carmustine—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Tolcapone—Headache—Carmustine—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Tolcapone—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000763	0.000763	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—lymphatic system cancer	0.000753	0.000753	CcSEcCtD
Tolcapone—Vomiting—Vincristine—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Tolcapone—Rash—Vincristine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Tolcapone—Dermatitis—Vincristine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Tolcapone—Headache—Vincristine—lymphatic system cancer	0.000741	0.000741	CcSEcCtD
Tolcapone—Nausea—Carmustine—lymphatic system cancer	0.000736	0.000736	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—lymphatic system cancer	0.000732	0.000732	CcSEcCtD
Tolcapone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000732	0.000732	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000728	0.000728	CcSEcCtD
Tolcapone—Rash—Mitoxantrone—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Tolcapone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Tolcapone—Chills—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Tolcapone—Headache—Mitoxantrone—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Tolcapone—Alopecia—Methotrexate—lymphatic system cancer	0.000713	0.000713	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—lymphatic system cancer	0.000707	0.000707	CcSEcCtD
Tolcapone—Nausea—Vincristine—lymphatic system cancer	0.000702	0.000702	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—lymphatic system cancer	0.000688	0.000688	CcSEcCtD
Tolcapone—Nausea—Mitoxantrone—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—lymphatic system cancer	0.000662	0.000662	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000652	0.000652	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Tolcapone—Malaise—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—lymphatic system cancer	0.000631	0.000631	CcSEcCtD
Tolcapone—Cough—Methotrexate—lymphatic system cancer	0.000613	0.000613	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—lymphatic system cancer	0.000598	0.000598	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—lymphatic system cancer	0.000591	0.000591	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—lymphatic system cancer	0.000578	0.000578	CcSEcCtD
Tolcapone—Infection—Methotrexate—lymphatic system cancer	0.00057	0.00057	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—lymphatic system cancer	0.000557	0.000557	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000554	0.000554	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—lymphatic system cancer	0.000536	0.000536	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000523	0.000523	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000515	0.000515	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—lymphatic system cancer	0.00051	0.00051	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000505	0.000505	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000499	0.000499	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000495	0.000495	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—lymphatic system cancer	0.000494	0.000494	CcSEcCtD
Tolcapone—Pain—Methotrexate—lymphatic system cancer	0.00049	0.00049	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000473	0.000473	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000469	0.000469	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—lymphatic system cancer	0.000456	0.000456	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000453	0.000453	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000453	0.000453	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000423	0.000423	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—lymphatic system cancer	0.000412	0.000412	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—lymphatic system cancer	0.000406	0.000406	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—lymphatic system cancer	0.000379	0.000379	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—lymphatic system cancer	0.000365	0.000365	CcSEcCtD
Tolcapone—Rash—Methotrexate—lymphatic system cancer	0.000362	0.000362	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—lymphatic system cancer	0.000361	0.000361	CcSEcCtD
Tolcapone—Headache—Methotrexate—lymphatic system cancer	0.000359	0.000359	CcSEcCtD
Tolcapone—Nausea—Methotrexate—lymphatic system cancer	0.000341	0.000341	CcSEcCtD
